Literature DB >> 18021752

Transepithelial transport of hesperetin and hesperidin in intestinal Caco-2 cell monolayers.

Shoko Kobayashi1, Soichi Tanabe, Masanori Sugiyama, Yutaka Konishi.   

Abstract

The cell permeability of hesperetin and hesperidin, anti-allergic compounds from citrus fruits, was measured using Caco-2 monolayers. In the presence of a proton gradient, hesperetin permeated cells in the apical-to-basolateral direction at the rate (Jap-->bl) of 10.43+/-0.78 nmol/min/mg protein, which was more than 400-fold higher than that of hesperidin (0.023+/-0.008 nmol/min/mg protein). The transepithelial flux of hesperidin, both in the presence or absence of a proton gradient, was nearly the same and was inversely correlated with the transepithelial electrical resistance (TER), indicating that the transport of hesperidin was mainly via paracellular diffusion. In contrast, the transepithelial flux of hesperetin was almost constant irrespective of the TER. Apically loaded NaN3 or carbonyl cyanide m-chlorophenylhydrazone (CCCP) decreased the Jap-->bl of hesperetin, in the presence of proton gradient, by one-half. In the absence of a proton gradient, both Jap-->bl and Jbl-->ap of hesperetin were almost the same (5.75+/-0.40 and 5.16+/-0.73 nmol/min/mg protein). Jbl-->ap of hesperetin in the presence of a proton gradient was lower than Jbl-->ap in the absence of a proton gradient. Furthermore, Jbl-->ap in the presence of a proton gradient remarkably increased upon addition of NaN3 specifically to the apical side. These results indicate that hesperetin is absorbed by transcellular transport, which occurs mainly via proton-coupled active transport, and passive diffusion. Thus, hesperetin is efficiently absorbed from the intestine, whereas hesperidin is poorly transported via the paracellular pathway and its transport is highly dependent on conversion to hesperetin via the hydrolytic action of microflora. We have given novel insight to the absorption characteristics of hesperetin, that is proton-coupled and energy-dependent polarized transport.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18021752     DOI: 10.1016/j.bbamem.2007.08.020

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Passive asymmetric transport of hesperetin across isolated rabbit cornea.

Authors:  Ramesh Srirangam; Soumyajit Majumdar
Journal:  Int J Pharm       Date:  2010-05-09       Impact factor: 5.875

2.  Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: a natural bioflavonoid.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  Pharm Res       Date:  2008-09-23       Impact factor: 4.200

3.  In vivo pharmacokinetics of hesperidin are affected by treatment with glucosidase-like BglA protein isolated from yeasts.

Authors:  Yong-Mei Li; Xiao-Mian Li; Guang-Ming Li; Wen-Cai Du; Jing Zhang; Wei-Xia Li; Jianshe Xu; Ming Hu; Ze Zhu
Journal:  J Agric Food Chem       Date:  2008-06-21       Impact factor: 5.279

4.  The protective effect of the natural compound hesperetin against fulminant hepatitis in vivo and in vitro.

Authors:  Xueting Bai; Peixuan Yang; Qiaoling Zhou; Bozhi Cai; Manon Buist-Homan; He Cheng; Jiyang Jiang; Daifei Shen; Lijun Li; Xiajiong Luo; Klaas Nico Faber; Han Moshage; Ganggang Shi
Journal:  Br J Pharmacol       Date:  2016-11-28       Impact factor: 8.739

5.  Characterization of in vitro ADME properties of diosgenin and dioscin from Dioscorea villosa.

Authors:  Vamshi K Manda; Bharathi Avula; Zulfiqar Ali; Yan-Hong Wong; Troy J Smillie; Ikhlas A Khan; Shabana I Khan
Journal:  Planta Med       Date:  2013-08-22       Impact factor: 3.352

6.  Flavonoids from Engineered Tomatoes Inhibit Gut Barrier Pro-inflammatory Cytokines and Chemokines, via SAPK/JNK and p38 MAPK Pathways.

Authors:  Matthew L Tomlinson; Eugenio Butelli; Cathie Martin; Simon R Carding
Journal:  Front Nutr       Date:  2017-12-18

7.  Influence of Hesperidin on the Systemic and Intestinal Rat Immune Response.

Authors:  Mariona Camps-Bossacoma; Àngels Franch; Francisco J Pérez-Cano; Margarida Castell
Journal:  Nutrients       Date:  2017-06-06       Impact factor: 5.717

8.  Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers.

Authors:  T Hidalgo; M Giménez-Marqués; E Bellido; J Avila; M C Asensio; F Salles; M V Lozano; M Guillevic; R Simón-Vázquez; A González-Fernández; C Serre; M J Alonso; P Horcajada
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

9.  Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Ahmed Kandeil; Ahmed Mostafa; Omnia Kutkat; Yassmin Moatasim; Ahmed A Al-Karmalawy; Adel A Rashad; Ahmed E Kayed; Azza E Kayed; Rabeh El-Shesheny; Ghazi Kayali; Mohamed A Ali
Journal:  Pathogens       Date:  2021-06-15

10.  Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin.

Authors:  Huiyi Wu; Xiaoying Long; Fei Yuan; Li Chen; Sujing Pan; Yunjun Liu; Yoshiko Stowell; Xiaoling Li
Journal:  Acta Pharm Sin B       Date:  2014-04-29       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.